FRONTEO,Inc. (2158)

Market cap
¥32B
P/E ratio
51.9x
FRONTEO provides AI-powered solutions for drug discovery, compliance, and legal investigations using its proprietary KIBIT technology to serve healthcare, corporate, and legal clients.
Period EndProperty, plant and equipment, net (Million JPY)YoY (%)
Mar 31, 2025299-6.93%
Mar 31, 2024322-24.68%
Mar 31, 2023427-39.71%
Mar 31, 2022709-39.12%
Mar 31, 20211,164+79.56%
Mar 31, 2020648-12.82%
Mar 31, 2019743-2.54%
Mar 31, 2018763-35.18%
Mar 31, 20171,177+6.47%
Mar 31, 20161,105+41.10%
Mar 31, 2015783
AI Chat